Columbia University Deploys AI to Crack the Code of Cancer, Alzheimer's, and Human Biology

Columbia University researchers are deploying cutting-edge AI tools to decode the molecular complexity of human biology, uncovering hidden genetic drivers of pediatric leukemia, Alzheimer's, and cancer in a landmark shift toward predictive, personalized medicine.

• Columbia University researchers are leveraging artificial intelligence to decode the overwhelming complexity of human biology, using AI to analyze data from trillions of cells and millions of molecular interactions to advance understanding of cancer, Alzheimer's, and other diseases.
• A newly developed open-source AI tool called GET is enabling scientists to simulate and predict molecular interactions across all major cell types, leading to the discovery of previously unknown genetic mechanisms behind pediatric leukemia and opening new doors for epigenetic research.
• Multiple Columbia research teams are unveiling cutting-edge AI-powered tools — including models tracking immune-cancer cell dynamics and identifying key Alzheimer's genetic drivers — signaling a broader shift toward biology becoming a predictive science capable of powering personalized medicine.